Procyrion Aortix - Percutaneous Mechanical Circulatory Support (pMCS) Device

• DESIGNED TO REDUCE CARDIAC WORKLOAD
• DESIGNED TO INCREASE RENAL PERFUSION
• PERCUTANEOUS DEPLOYMENT IN < 10 MIN

• A portion of the native flow enters the pump at the inlet
• The flow is accelerated in the pump and exits the device in high velocity jets directed downstream
• The high velocity jets entrain the native flow, transferring momentum and energy to it
• The result is a net increase in overall velocity and aortic flow

AORTIX`S NOVEL TECHNOLOGY UNIQUELY ADDRESSES CARDIORENAL SYNDROME
Resting the heart while perfusing the kidneys, Aortix™ aims to treat heart failure symptoms by disrupting the cardiorenal syndrome cycle.